Open AccessFour-week pegylated interferon a-2a monotherapy for chronic hepatitis C with genotype 2 and low viral load: A pilot, randomized study
Author(s) -
Akihito Tsubota,
Keisuke Satoh,
Mashu Aizawa,
Seishi Takamatsu,
Yoshihisa Namiki,
Toshifumi Ohkusa,
Kiyotaka Fujise,
Hisao Tajiri
Publication year - 2008
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.14.7220
Subject(s) - medicine , pegylated interferon , gastroenterology , alpha interferon , viral load , interferon , interferon alfa , chronic hepatitis , peg ratio , immunology , ribavirin , virus , finance , economics
To assess the efficacy and advantages of 4-wk pegylated interferon alpha-2a (peg-IFN-alpha 2a) monotherapy for chronic hepatitis C patients with strong predictors of sustained virologic response (SVR).